Surgical tissue sampling and cancer detection
A catheter treatment apparatus comprises an elongate tubular member and an expandable support. The expandable support comprises a radioactive substance to treat cancerous tissue and is configured to expand from a narrow profile for insertion to a wide profile to engage and treat tissue remaining after resection. The expandable support can be sized to fit within a volume of removed tissue to place the radioactive substance in proximity to the capsule and remaining tissue, to spare the capsule and proximate nerves and vessels to treat tissue in proximity to the capsule. The elongate tubular member may comprise a channel such as a lumen to pass a bodily fluid such as urine when the expandable support engages the tissue to treat the patient for a plurality of days. The treatment apparatus can be used to resect and diagnose tissue concurrently. Based on the diagnosis, targeted segmental treatment may be given.
1. A method of treating a patient, the method comprising:
placing the patient on a patient support;
removing a sample of a tissue from the patient using a water jet source; and
receiving the sample using a device; and
determining, using the device, whether the sample comprises cancerous tissue while the patient is on the patient support;
wherein a treatment probe comprising the water jet source is inserted into the patient;
wherein an ultrasound probe is inserted into the patient and images a water jet released from the water jet source while the sample is removed from the patient.
2. The method of claim 1 , wherein the tissue is removed when the patient has been placed on the patient support.
3. The method of claim 1 , wherein the device is configured to receive the sample when the patient remains on the patient support and provide a diagnosis while the patient remains on the patient support.
4. The method of claim 1 , wherein determining whether the sample comprises cancerous tissue in response to the tissue removed from the patient comprises one or more of testing for optical absorption and scattering on the tissue, performing fluorescence spectroscopy on the tissue, or performing optical coherence domain reflectometry on the tissue.
5. The method of claim 1 , wherein determining whether the sample comprises cancerous tissue in response to the tissue removed from the patient comprises determining whether the tissue comprises cancerous tissue in real-time concurrently with removing the sample of the tissue.
6. The method of claim 1 , wherein determining whether the sample comprises cancerous tissue in response to the tissue removed further comprises determining whether the tissue comprises pre-cancerous tissue.
7. The method of claim 1 , wherein the tissue comprises prostate tissue.
8. The method of claim 1 , wherein the device is configured to identify one or more biomarkers of a cancer.
9. The method of claim 1 , wherein the treatment probe is coupled to a flushing source to flush the tissue while the sample is removed.
10. The method of claim 1 , wherein the treatment probe comprises an aspiration port to collect the sample of the tissue.
11. The method of claim 10 , wherein the aspiration port comprises a plurality of aspiration ports.
12. The method of claim 1 , further comprising a handpiece and wherein the treatment probe extends though the handpiece toward the tissue.